76 years ago, India was born free. Since then, our country has undertaken a remarkable journey of progress, innovation, and development in almost every field, including healthcare and pharmaceuticals. Along with our member companies, we have been working relentlessly to ensure that no corner of our nation is left untouched by access to quality healthcare. We’ve been investing in modern treatments, expanding research centres in partnership with the government, and providing access to new vaccines and therapies to those in need. As we progress towards India@100, our commitment to the country’s healthcare needs grows stronger. Together, we will continue to enable freedom from diseases, inaccessibility of medicines, and unmet medical needs. Happy #IndependenceDay! #BharatKeLiye Ministry of Health and Family Welfare, Government of India
OPPI India
Pharmaceutical Manufacturing
Mumbai, Maharashtra 6,641 followers
Partnering India since pre-independence to improve patient safety & provide healthcare access to all. #BharatKeLiye
About us
The Organisation of Pharmaceutical Producers of India (OPPI) was established in 1965 and represents the research-based pharmaceutical companies in India. OPPI remains committed to supporting the nation’s healthcare objectives and collaborating with all stakeholders to find sustainable solutions. OPPI believes the need for innovation must be balanced with the necessity for more accessible medicines, within a robust IP environment. Vision: OPPI is an organisation of research and innovation driven pharmaceutical companies committed to addressing India's healthcare needs by: - Facilitating greater access to quality healthcare solutions - Encouraging research and innovation - Disseminating knowledge and sharing best practices - Contributing meaningfully in policy dialogues Focus Areas: 1. Support innovation for the benefit of India - OPPI members have a proven track record of innovation - Members recognise unmet medical needs and address therapeutic areas with innovation-driven cures 2. Promote access to healthcare - Partnering with industry to define what constitutes access - Working to bring together stakeholders for a common cause 3. Adhere to high standards of Ethics & Compliance - Members abide by OPPI’s stringent Code of Pharmaceutical Practices - Committed to following Current Good Manufacturing Practices (CGMP)
- Website
-
https://www.indiaoppi.com/
External link for OPPI India
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Mumbai, Maharashtra
- Type
- Nonprofit
- Founded
- 1965
- Specialties
- Health Policy, Health Advocacy, Scientific Research, Innovation, and Multi-stakeholder Collaboration
Locations
-
Primary
Get directions
Peninsula Chambers, Ground Floor, Ganpatrao Kadam Marg, Lower Parel
Mumbai, Maharashtra 400013, IN
Employees at OPPI India
-
Gurulingam Mallappan
BU Head - Public Market and Market Access at Servier India Pvt Ltd
-
PRASHANT SHARMA
Director - Government Affairs
-
Ankit Shikhar
Dynamic reliable resourceful individual capable of handling anything.
-
Clara Rodricks
Management Secretary at Organisation of Pharmaceutical Producers of India
Updates
-
The OPPI Scientist Awards 2024 offers a unique chance to showcase your groundbreaking #research in pharmaceutical sciences. To learn more about the #award criteria and how to register, click here: https://lnkd.in/dt3X6U48
-
The OPPI Excellence in Innovation Healthcare Start-up Award offers a unique chance to showcase your groundbreaking work in healthcare. To learn more about the award criteria and how to register, click here: https://lnkd.in/g6S4fZUT
-
-
Ferring Pharmaceuticals’ GCC is transforming healthcare with its ‘local to local’ and ‘local to global’ approach. By developing global-standard pharma products in India, Ferring is enhancing patient safety and quality, making a significant impact both locally and globally. #ValueOfInnovation #BharatKeLiye
-
Anil Matai, DG OPPI, will be participating as a speaker at the 6th Elets Pharma Leadership Summit & Awards 2024, presented by Elets Technomedia, in collaboration with eHealth Magazine. Do join this insightful session live on August 30th. Register now: https://bit.ly/3XIDD6H
Harness the Power of Innovations & Drive Growth to Build A Resilient, Forward-Thinking Pharma Ecosystem! Join us at the 6th Elets Pharma Leadership Summit & Awards 2024, organised by Elets Technomedia & powered by eHealth Magazine, and hear latest insights from Anil Matai, Director General, Organisation of Pharmaceutical Producers of India (OPPI) Get ready for an insightful session on the latest innovations in the pharma industry. 📅 Date: 30th August 2024 📍 Location: Novotel- Juhu Beach, Mumbai Register Now:- https://bit.ly/3XIDD6H Don't miss this opportunity to network with industry leaders and gain valuable knowledge! #EletsPharma #PharmaSummit2024
-
-
The Government of India’s Amrit Kaal blueprint - Vision Pharma 2047 - wonderfully underscores their commitment towards fostering research and innovation. As Anil Matai, Director General at OPPI writes in his piece for BW Healthcare World, this will help enable an essential pivot from volume-based to value-based for the pharmaceutical industry in India. Read the full piece here: https://lnkd.in/gK_WHG5A
-
As we celebrate India’s 78th Independence Day today, we applaud the strides made in healthcare, like in other spheres. OPPI and its member companies have and will continue to support the government in its endeavours to further advance the country’s healthcare ecosystem. Sab Ke Saath, Sab Ke Liye! #BharatKeLiye #IndependenceDay
-
In alignment with the government’s vision, OPPI and our member companies are at the forefront of innovation and research, driving progress to meet international standards of excellence. Stay tuned for more! #BharatKeLiye
-
-
In this new piece for ET Pharma, Anil Matai, Director General of OPPI talks about the need for a robust IP framework for the pharmaceutical sector to aid further innovation in the country. He shares how rewarding inventors for their work will go a long way in motivating them to continue their work in R&D and manufacturing alike. Read the full story here: https://lnkd.in/gyzW68yn
Fostering Innovation and Growth: The Need for a Robust Intellectual Property Framework An effective IP framework serves as both a guardian and an enabler. It guards the results of ingenuity, ensuring that inventors are duly rewarded for their contributions. Simultaneously, it acts as an enabler, fostering an environment where businesses can confidently invest in research, development, and manufacturing, knowing that their IP rights are secure. #intellectualproperty I #redefinehealthoutcomes I #patentsamendmentrules I #indigenouscompanies I #technologicalbreakthroughs I #healthoutcomes I #Healthcare I Anil Matai I Organisation of Pharmaceutical Producers of India Read more: https://lnkd.in/gyzW68yn
Fostering Innovation and Growth: The Need for a Robust Intellectual Property Framework - ETPharma
pharma.economictimes.indiatimes.com
-
Eli Lilly India’s Capability Centre leads in integrating technology and biotechnology, creating advanced tools and methods that accelerate the discovery of new and effective medicines for patients worldwide. #ValueOfInnovation #BharatKeLiye Lilly Capability Center India